These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29737150)

  • 21. Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response.
    Belcaro G; Rohdewald P; Cesarone MR; Scipione C; Scipione V; Cornelli U; Luzzi R; Cotellese R; Dugall M; Hosoi M; Corsi M; Feragalli B
    Panminerva Med; 2022 Jun; 64(2):253-258. PubMed ID: 35815767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.
    Belcaro G; Cesarone MR; Cornelli U; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Hosoi M; Maione C; Cotellese R; Cesinaro Di Rocco P
    Minerva Stomatol; 2019 Dec; 68(6):303-307. PubMed ID: 32052619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pycnogenol® in postpartum symptomatic hemorrhoids.
    Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
    Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
    Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
    J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
    Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
    Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary benign back pain: supplementation with Pycnogenol®.
    Cox D; Belcaro G; Cesarone MR; Cotellese R; Dugall M; Feragalli B; Hosoi M; Corsi M; Luzzi R
    Panminerva Med; 2021 Dec; 63(4):472-477. PubMed ID: 34915691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study.
    Rai RR; Dwivedi M; Kumar N
    Saudi J Gastroenterol; 2014; 20(6):378-82. PubMed ID: 25434320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives.
    Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V
    Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
    Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.
    Feragalli B; Dugall M; Luzzi R; Ledda A; Hosoi M; Belcaro G; Cesarone MR
    Minerva Endocrinol; 2019 Mar; 44(1):97-101. PubMed ID: 30561176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
    Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign prostatic hypertrophy: Pycnogenol® supplementation improves prostate symptoms and residual bladder volume.
    Ledda A; Belcaro G; Feragalli B; Cornelli U; Dugall M; Corsi M; Cesarone MR
    Minerva Med; 2018 Aug; 109(4):280-284. PubMed ID: 29947491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study.
    Belcaro G; Dugall M; Hosoi M; Feragalli B; Cotellese R; Saggino A; Cesarone MR; Ippolito E; Cornelli U; Ledda A; Cox DB
    J Neurosurg Sci; 2024 Feb; 68(1):109-116. PubMed ID: 38299491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
    Luzzi R; Belcaro G; Ippolito E
    Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.